CoChat

Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica

Kim, Su-Hyun, Kim, Woojun, Park, Min Su, Sohn, Eun Hee, Li, Xue Feng, Kim, Ho Jin · 2011 · Archives of Neurology
Cited by 98

The DOI matches its Crossref record.

Abstract

OBJECTIVE: To evaluate the efficacy and safety of mitoxantrone hydrochloride and determine how it exhibits a differential inhibitory effect on subsets of B cells in patients with highly relapsing neuromyelitis optica (NMO). DESIGN: Retrospective case series with prospective follow-up. SETTING: Three referral medical centers in the Republic of Korea. PATIENTS: Twenty patients with highly relapsing NMO or neuromyelitis optica spectrum disorder who had at least 2 relapses during the year preceding the start of mitoxantrone treatment, despite other immunotherapies. INTERVENTION: Infusions of mitoxantrone up to a maximum cumulative dose of 120 mg/m(2). MAIN OUTCOME MEASURES: Annualized relapse rate, disability according to the Expanded Disability Status Scale score, and fraction of CD27(+)CD19(+) memory B cells. RESULTS: During mitoxantrone treatment, the median annualized relapse rate was reduced by 75%, and 50% of patients became relapse free. Disability improved or stabilized in all patients. No patients had serious adverse effects during the mean follow-up period of 41 months after completing therapy. Flow cytometric analysis of cell surface markers revealed that mitoxantrone treatment preferentially affected CD27(+)CD19(+) memory B cells. CONCLUSIONS: Treatment with mitoxantrone in patients with highly relapsing NMO significantly reduces relapse rates, resulting in subsequent functional stabilization or improvement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/archneurol.2010.322

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 98

Metadata

Authors
Kim, S.-H., Kim, W., Park, M. S., Sohn, E. H., Li, X. F., & Kim, H. J.
Venue
Archives of Neurology
Published
2011-04-11
Volume
68
Issue
4
Pages
473
ISSN
0003-9942 (ISSN-L)
OpenAlex
W2140716285
Cited by
98
References
0
FWCI
6.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica. https://app.cochat.ai/papers/10.1001/archneurol.2010.322
The paper
Kim, S.-H., Kim, W., Park, M. S., Sohn, E. H., Li, X. F., & Kim, H. J. (2011). Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica. Archives of Neurology. https://doi.org/10.1001/archneurol.2010.322

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.